(Q28194215)

English

New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartion

scientific article (publication date: November 2002)

In more languages

edit

Statements

0 references

0 references

New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartion (English)

0 references

author name string

Patricia A Howard

series ordinal

1

0 references

language of work or name

English

0 references

publication date

November 2002

0 references

published in

Annals of Pharmacotherapy

0 references

volume

36

0 references

issue

11

0 references

page(s)

1800-4

0 references

cites work

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345/APH.1C274

retrieved

21 April 2017

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Thrombotic thrombocytopenic purpura associated with clopidogrel

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Is CURE a cure for acute coronary syndromes? Statistical versus clinical significance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Dalteparin in combination with abciximab during percutaneous coronary intervention

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

The SYNERGY trial: study design and rationale

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1C274

retrieved

21 January 2018

Identifiers

DOI

10.1345/APH.1C274

0 references

PubMed publication ID

12432893

0 references

(Q28194215)

New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartion

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)